Use of marginal organs in kidney transplantation for marginal recipients: too close to the margins of safety? 2010

M Heuer, and A Zeiger, and G M Kaiser, and Z Mathé, and A Goldenberg, and S Sauerland, and A Paul, and Jürgen W Treckmann
Department of General-, Visceral- and Transplantation Surgery, University Hospital of Essen, 45122 Essen, Germany.

OBJECTIVE Due to organ shortage, average waiting time for a kidney in Germany is about 4 years after start of dialysis. Number of kidney grafts recovered can only be maintained by accepting older and expanded criteria donors. The aim of this study was to analyse the impact of donor and recipient risk on kidney long-term function. METHODS All deceased kidney transplantations were considered. We retrospectively studied 332 patients between 2002 and 2006; divided in 4 groups reflecting donor and recipient risk. RESULTS Non-marginal recipients were less likely to receive a marginal organ (69 of 207, 33%) as compared to marginal recipients, of whom two-thirds received a marginal organ (p<0.0001). Graft function significantly differed between the groups, but detrimental effect of marginal recipient status on eGFR after 12 months (-6 ml/min/1.73qm, 95% CI -2 to -9) was clearly smaller than the effect of marginal donor status (-10 ml/min/1.73qm, 95% CI -7 to -14). CONCLUSIONS As we were able to show expanded criteria donor has a far bigger effect on long-term graft function than the "extra risk" recipient. Although there have been attempts to define groups of recipients who should be offered ECD kidneys primarily the discussion is still ongoing.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D007902 Length of Stay The period of confinement of a patient to a hospital or other health facility. Hospital Stay,Hospital Stays,Stay Length,Stay Lengths,Stay, Hospital,Stays, Hospital
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009927 Tissue and Organ Procurement The administrative procedures involved with acquiring TISSUES or organs for TRANSPLANTATION through various programs, systems, or organizations. These procedures include obtaining consent from TISSUE DONORS and arranging for transportation of donated tissues and organs, after TISSUE HARVESTING, to HOSPITALS for processing and transplantation. Organ Procurement,Organ Procurement Systems,Organ Shortage,Tissue Procurement,Tissue Shortage,Donor Cards,Organ Donation,Required Organ Donation Request,Required Request,Tissue Donation,Donor Card,Organ Donations,Organ Procurement System,Organ Procurements,Required Requests,Shortage, Tissue,Tissue Donations,Tissue Procurements,Tissue Shortages
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003422 Critical Care Health care provided to a critically ill patient during a medical emergency or crisis. Intensive Care,Intensive Care, Surgical,Surgical Intensive Care,Care, Critical,Care, Intensive,Care, Surgical Intensive
D005260 Female Females
D005858 Germany A country in central Europe, bordering the Baltic Sea and the North Sea, between the Netherlands and Poland, south of Denmark. The capital is Berlin.
D006648 Histocompatibility The degree of antigenic similarity between the tissues of different individuals, which determines the acceptance or rejection of allografts. HLA Incompatibility,Histoincompatibility,Human Leukocyte Antigen Incompatibility,Immunocompatibility,Tissue Compatibility,Compatibility, Tissue,HLA Incompatibilities,Histocompatibilities,Histoincompatibilities,Immunocompatibilities,Incompatibility, HLA,Tissue Compatibilities

Related Publications

M Heuer, and A Zeiger, and G M Kaiser, and Z Mathé, and A Goldenberg, and S Sauerland, and A Paul, and Jürgen W Treckmann
December 2002, Transplantation proceedings,
M Heuer, and A Zeiger, and G M Kaiser, and Z Mathé, and A Goldenberg, and S Sauerland, and A Paul, and Jürgen W Treckmann
September 2002, Transplantation proceedings,
M Heuer, and A Zeiger, and G M Kaiser, and Z Mathé, and A Goldenberg, and S Sauerland, and A Paul, and Jürgen W Treckmann
January 2019, Frontiers in immunology,
M Heuer, and A Zeiger, and G M Kaiser, and Z Mathé, and A Goldenberg, and S Sauerland, and A Paul, and Jürgen W Treckmann
August 2002, Transplantation proceedings,
M Heuer, and A Zeiger, and G M Kaiser, and Z Mathé, and A Goldenberg, and S Sauerland, and A Paul, and Jürgen W Treckmann
March 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
M Heuer, and A Zeiger, and G M Kaiser, and Z Mathé, and A Goldenberg, and S Sauerland, and A Paul, and Jürgen W Treckmann
February 2022, Current opinion in organ transplantation,
M Heuer, and A Zeiger, and G M Kaiser, and Z Mathé, and A Goldenberg, and S Sauerland, and A Paul, and Jürgen W Treckmann
January 2011, Transplantation proceedings,
M Heuer, and A Zeiger, and G M Kaiser, and Z Mathé, and A Goldenberg, and S Sauerland, and A Paul, and Jürgen W Treckmann
April 2016, Transplantation proceedings,
M Heuer, and A Zeiger, and G M Kaiser, and Z Mathé, and A Goldenberg, and S Sauerland, and A Paul, and Jürgen W Treckmann
May 2006, Transplantation proceedings,
M Heuer, and A Zeiger, and G M Kaiser, and Z Mathé, and A Goldenberg, and S Sauerland, and A Paul, and Jürgen W Treckmann
November 2021, Biomedicines,
Copied contents to your clipboard!